Pharmaceutical composition for treating biliary cirrhosis
A technology of biliary cirrhosis and composition, applied in the field of medicine, can solve problems such as poor prognosis, few methods, and unsatisfactory curative effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
experiment example
[0018] Diagnostic criteria
[0019] Refer to the 2000 American Society for Liver Diseases (ASSLD) PBC diagnosis to specify (Heathcote EJ Managament of primary biliary cirrhosis The American Association for the Study of Liver Diseases Puactice Guideline Hepatology [J] 2000, 31: 1005-1013.). ①Cholestasis-related biochemical indicators such as elevated alkaline phosphatase (ALP); ②B-ultrasound or cholangiography showed normal bile ducts; ③Serum anti-mitochondrial antibody (AMA) or AMA-M subtype 2 was positive; ④Serum AMA / AMA -M 24 negative, liver biopsy pathology consistent with PBC. It can be diagnosed if it meets ①+②+③ or ①+②+④.
[0020] Select 52 patients who meet the above criteria, including 30 males and 22 females, aged 31-59 years. The average age is 39 years old. Clinical manifestations: pain in the liver area, anorexia, abdominal distension, fatigue, skin itching, joint pain, jaundice, hepatosplenomegaly, ascites, and edema of lower extremities. No serious diseases s...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com